NCT02921542View on ClinicalTrials.gov

An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

August 15, 2016

Primary Completion Date

May 15, 2018

Study Completion Date

May 1, 2019

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Laser Atherectomy

The Turbo-Power is laser atherectomy catheter designed for treatment of de novo or restenotic lesions in native infrainguinal arteries and for the treatment of femoropopliteal artery in-stent restenosis (ISR) in bare nitinol stents with adjunctive percutaneous transluminal angioplasty (PTA).

Trial Locations (1)

27607

Rex Hospital, Raleigh

All Listed Sponsors
lead

Spectranetics Corporation

INDUSTRY

NCT02921542 - An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies | Biotech Hunter | Biotech Hunter